Spark Therapeutics

NextHealth PHL

Former Spark Therapeutics COO Appointed CEO of Imvax

When John Furey retired from his role as chief operating officer at Spark Therapeutics in November 2018, he had plans to take it easy. He […]

NextHealth PHL

Why the $4.3 Billion Spark Therapeutics Deal Is Still Delayed

This week, Swiss multinational healthcare company Roche announced yet another delay in the company’s intended $4.3 billion acquisition of Philadelphia-based gene therapy company Spark Therapeutics. Spark […]

NextHealth PHL

Why the Country’s Top Biotech Companies Are Flocking to Philadelphia

The leaders behind some of the most successful biotech companies in the country have chosen to grow their businesses in Philadelphia because, even when compared to […]

Business

The $850K, Philly-Developed Blindness Treatment That Could Be the Gateway to Curing Big Disease

Last month, the U.S. Food and Drug Administration (FDA) announced its approval of Spark Therapeutics’ Luxturna, a one-time treatment for adults and children with a […]

Business

Spark Therapeutics Gene Therapy for Blindness Moves Forward With FDA

There’s a greater chance now than ever before that the Food and Drug Administration‘s first two approved gene therapies will both come from Philadelphia. This week, […]